Research Grants 12 show all


$250K
2002

$124K
2003

$592.7K
2004

$640K
2005

$391.8K
2006

Patents 474show all

  • 239
    A61K - Preparations for medical, dental, or toilet purposes
  • 128
    C07K - Peptides
  • 50
    C07D - Heterocyclic compounds
  • 35
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 12
    A61J - Containers specially adapted for medical or pharmaceutical purposes
  • 12
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 6
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 5
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 3
    C12N - Microorganisms or enzymes
  • 1
    C12M - Apparatus for enzymology or microbiology

Clinical Trials 49show all

16Phase 213Phase 112N/A7Phase 3

SEC Filings show all


84
8-K

24
10-Q

8
10-K

3
D

1
S-1

Contact Information

Lafayette, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2010-12-23$15,000,000$8,100,000Debt, Option to Acquire, Security to be Acquired
2009-10-26$30,000,002$26,645,523Equity
2003-05-21Unknown Unknown Other (Paper Filing)

Key Executives

  • P. Ron Ellis
    Executive Officer, Director
  • John C. Aplin
    Director
  • Douglas B. Bailey
    Director
  • Keith Brauer
    Director
  • Jack Clawson
    Director
  • Ann F. Hanham
    Director
  • Philip S. Low
    Director
  • Fred A. Middleton
    Director
  • Mike Sherman
    Executive Officer
  • Douglas G. Bailey
    Director
  • Keith E. Brauer
    Director
  • John C. Clawson
    Director
  • Michael A. Sherman
    Executive Officer
  • James S. Shannon
    Director